Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis.

Paquet-Fifield S, Levy SM, Sato T, Shayan R, Karnezis T, Davydova N, Nowell CJ, Roufail S, Ma GZ, Zhang YF, Stacker SA, Achen MG.

J Invest Dermatol. 2013 Aug;133(8):2074-84. doi: 10.1038/jid.2013.83. Epub 2013 Feb 25.

2.

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG.

Mol Cell Biol. 2005 Mar;25(6):2441-9.

3.

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, Rupasinghe TW, Tull DL, Baldwin ME, Sloan EK, Fox SB, Achen MG, Stacker SA.

Cancer Cell. 2012 Feb 14;21(2):181-95. doi: 10.1016/j.ccr.2011.12.026.

4.

Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.

Ji RC, Miura M, Qu P, Kato S.

Microsc Res Tech. 2004 Jun 15;64(3):279-86.

PMID:
15452895
5.

VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.

Koch M, Dettori D, Van Nuffelen A, Souffreau J, Marconcini L, Wallays G, Moons L, Bruyère F, Oliviero S, Noel A, Foidart JM, Carmeliet P, Dewerchin M.

J Pathol. 2009 Nov;219(3):356-64. doi: 10.1002/path.2605.

PMID:
19718705
6.

Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.

Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, Stacker SA, Achen MG, Alitalo K.

Mol Cell Biol. 2008 Aug;28(15):4843-50. doi: 10.1128/MCB.02214-07. Epub 2008 Jun 2.

7.

Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer.

Girling JE, Donoghue JF, Lederman FL, Cann LM, Achen MG, Stacker SA, Rogers PA.

Reprod Biol Endocrinol. 2010 Jul 8;8:84. doi: 10.1186/1477-7827-8-84.

8.

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG.

Nat Med. 2001 Feb;7(2):186-91.

PMID:
11175849
9.

An important role of lymphatic vessel activation in limiting acute inflammation.

Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M, Werner S, Alitalo K, Detmar M.

Blood. 2011 Apr 28;117(17):4667-78. doi: 10.1182/blood-2010-10-316356. Epub 2011 Mar 1.

10.

A system for quantifying the patterning of the lymphatic vasculature.

Shayan R, Karnezis T, Tsantikos E, Williams SP, Runting AS, Ashton MW, Achen MG, Hibbs ML, Stacker SA.

Growth Factors. 2007 Dec;25(6):417-25. doi: 10.1080/08977190801932550.

PMID:
18365872
11.

The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.

Harris NC, Davydova N, Roufail S, Paquet-Fifield S, Paavonen K, Karnezis T, Zhang YF, Sato T, Rothacker J, Nice EC, Stacker SA, Achen MG.

J Biol Chem. 2013 Mar 22;288(12):8176-86. doi: 10.1074/jbc.M112.439299. Epub 2013 Feb 12.

12.

Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.

Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL.

J Surg Res. 2001 Apr;96(2):173-82.

PMID:
11266270
13.

Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.

Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA.

Am J Pathol. 2007 Apr;170(4):1178-91.

14.

Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.

Kopfstein L, Veikkola T, Djonov VG, Baeriswyl V, Schomber T, Strittmatter K, Stacker SA, Achen MG, Alitalo K, Christofori G.

Am J Pathol. 2007 Apr;170(4):1348-61.

15.

MFG-E8 regulates angiogenesis in cutaneous wound healing.

Uchiyama A, Yamada K, Ogino S, Yokoyama Y, Takeuchi Y, Udey MC, Ishikawa O, Motegi S.

Am J Pathol. 2014 Jul;184(7):1981-90. doi: 10.1016/j.ajpath.2014.03.017. Epub 2014 May 15.

16.

Role of lymphangiogenic factors in tumor metastasis.

He Y, Karpanen T, Alitalo K.

Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12. Review.

PMID:
14984763
17.

Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.

Betterman KL, Paquet-Fifield S, Asselin-Labat ML, Visvader JE, Butler LM, Stacker SA, Achen MG, Harvey NL.

Am J Pathol. 2012 Dec;181(6):2225-38. doi: 10.1016/j.ajpath.2012.08.035. Epub 2012 Oct 11.

PMID:
23063660
18.

Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.

Karpanen T, Wirzenius M, Mäkinen T, Veikkola T, Haisma HJ, Achen MG, Stacker SA, Pytowski B, Ylä-Herttuala S, Alitalo K.

Am J Pathol. 2006 Aug;169(2):708-18.

19.

Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.

Blacker HA, Orgeig S.

J Comp Physiol B. 2012 Jan;182(1):109-26. doi: 10.1007/s00360-011-0604-0. Epub 2011 Jul 29.

PMID:
21800152
20.

Lymphatics in nanophysiology.

Hirakawa S, Detmar M, Karaman S.

Adv Drug Deliv Rev. 2014 Jul;74:12-8. doi: 10.1016/j.addr.2014.01.011. Epub 2014 Feb 10. Review.

PMID:
24524932
Items per page

Supplemental Content

Write to the Help Desk